Search For "serum institute"
Covid-19 fallout: SII signs deal with Astra Zeneca to manufacture vaccines
Updated : 5 years, 11 months ago IST
New Delhi [India], June 13 (ANI): Adar Poonawalla, CEO and Owner, Serum Institute of India (SII) on Saturday announced that his firm has signed a deal with Astra Zeneca to supply one billion doses of vaccine for low and middle-income countries before the end of 2020 to combat coronavirus.
Read More
New pneumococcal vaccine from Serum Institute of India achieves WHO prequa
Updated : 6 years, 5 months ago IST
Seattle (USA)/Pune (Maharashtra) [India] Dec 23 (ANI/NewsVoir): PNEUMOSIL®, a vaccine against a leading cause of deadly childhood pneumonia - the pneumococcus bacterium - has achieved prequalification by the World Health Organization (WHO).
Read More
Svasti Microfinance raises Rs. 34 crores from Nordic Microfinance Initiati
Updated : 7 years, 3 months ago IST
New Delhi [India], Feb 12 (ANI): Svasti Microfinance Private Limited (Svasti) has raised a total of Rs. 34 Crores capital from Nordic Microfinance Initiative (NMI), Serum Institute of India CEO Adar Poonawalla, and other investors.
Read More
Dr. Cyrus Poonawalla congratulated for life-long commitment to boosting va
Updated : 7 years, 5 months ago IST
New Delhi [India], Dec 17 (ANI-BusinessWireIndia): Dr. Cyrus Poonawalla, Founder of Serum Institute of India (SII) and Chairman of Poonawalla Group, has been given the first ever Vaccine Hero award by Gavi, the Vaccine Alliance.
Read More
Global Rotavirus vaccine options expand with WHO prequalification of new v
Updated : 7 years, 7 months ago IST
New Delhi [India], Sep 28 (NewsVoir): PATH welcomes the World Health Organization's (WHO's) prequalification of the thermostable rotavirus vaccine, ROTASIIL®, manufactured by Serum Institute of India.
Read More
Serum Institute's vaccine demonstrates significant efficacy against severe
Updated : 8 years, 7 months ago IST
Pune (Maharashtra) [India], Sept 26 (ANI-NewsVoir): Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.'s rotavirus vaccine BRV-PV (known as ROTASIIL) were published in the journal Vaccine.
Read More